ANKRD13A
Ankyrin repeat domain-containing protein 13A
Also known as: AN13A_HUMAN, ANKRD13, NY-REN-25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZ07
- Gene
- ANKRD13A
- Ensembl
- ENSG00000076513
- Chromosome
- 12
- Canonical length
- 590 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Enables ubiquitin-modified protein reader activity. Involved in negative regulation of protein localization to endosome and negative regulation of receptor internalization. Located in late endosome; perinuclear region of cytoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
590 residues, UniProt reviewed canonical sequence.
>Q8IZ07|ANKRD13A
1 MSSACDAGDH YPLHLLVWKN DYRQLEKELQ GQNVEAVDPR GRTLLHLAVS LGHLESARVL
61 LRHKADVTKE NRQGWTVLHE AVSTGDPEMV YTVLQHRDYH NTSMALEGVP ELLQKILEAP
121 DFYVQMKWEF TSWVPLVSRI CPNDVCRIWK SGAKLRVDIT LLGFENMSWI RGRRSFIFKG
181 EDNWAELMEV NHDDKVVTTE RFDLSQEMER LTLDLMKPKS REVERRLTSP VINTSLDTKN
241 IAFERTKSGF WGWRTDKAEV VNGYEAKVYT VNNVNVITKI RTEHLTEEEK KRYKADRNPL
301 ESLLGTVEHQ FGAQGDLTTE CATANNPTAI TPDEYFNEEF DLKDRDIGRP KELTIRTQKF
361 KAMLWMCEEF PLSLVEQVIP IIDLMARTSA HFARLRDFIK LEFPPGFPVK IEIPLFHVLN
421 ARITFGNVNG CSTAEESVSQ NVEGTQADSA SHITNFEVDQ SVFEIPESYY VQDNGRNVHL
481 QDEDYEIMQF AIQQSLLESS RSQELSGPAS NGGISQTNTY DAQYERAIQE SLLTSTEGLC
541 PSALSETSRF DNDLQLAMEL SAKELEEWEL RLQEEEAELQ QVLQLSLTDKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD13A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 62 nTPM
- testis: 57 nTPM
- lymph node: 50 nTPM
- appendix: 34 nTPM
- bone marrow: 34 nTPM
- spleen: 31 nTPM
Single-cell type
- neutrophils: 572 nCPM
- late spermatids: 258 nCPM
- neutrophil progenitors: 229 nCPM
- late primary spermatocytes: 160 nCPM
- esophageal apical cells: 151 nCPM
- alveolar cells type 1: 147 nCPM
Immune cell
- eosinophil: 5.7 nTPM
- neutrophil: 3.5 nTPM
- intermediate monocyte: 2.5 nTPM
- memory B-cell: 2 nTPM
- basophil: 1.5 nTPM
- MAIT T-cell: 1.5 nTPM
Brain region
- white matter: 32 nTPM
- basal ganglia: 22 nTPM
- medulla oblongata: 20 nTPM
- cerebellum: 20 nTPM
- midbrain: 19 nTPM
- cerebral cortex: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.47
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of receptor internalization
- negative regulation of protein localization to endosome
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ANKRD13A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD13A as an antibody target. Whether an autoantibody or antibody against ANKRD13A could matter depends on whether native ANKRD13A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD13A is annotated at the cell surface, where native ANKRD13A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ANKRD13A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...